Deep brain stimulation is a minimally invasive targeted surgery used to treat movement disorders in dystonia, Parkinson's disease, and essential tremor. Minimally invasive surgeries (MIS) offer several advantages over traditional surgical techniques. MIS minimizes trauma to the body, reduces postoperative pain, increases recovery speed, and improves outcomes. Robotic procedures represent the latest evolution in minimally invasive procedures, providing surgeons with precision equipment that uses the same small incisions used in traditional laparoscopy. MIS leads to less blood loss, less analgesic use, and shorter postoperative hospital stay than open surgery. In addition, minimally invasive surgery indicates a higher accuracy rate than traditional surgical methods. Also, these procedures require tiny incisions large enough to insert thin tubes and cameras. These benefits of MIS are increasing inpatients and have encouraged older patients who face high operative morbidity and mortality to seek surgery. Thus, the rising demand for minimally invasive surgeries due to their advantages bolsters the Europe deep brain stimulation (DBS) market growth.
In the medical field, neurosurgery requires advanced equipment and highly qualified medical professionals. German neurosurgeons are highly qualified specialists; they follow the latest protocols and surgical procedures. Neurology centers in Germany have the most modern diagnostic and minimally invasive surgical devices that meet international quality standards. According to a study published at Charité—Universitätsmedizin Berlin entitled “Deep brain stimulation in Parkinson's: A new algorithm to adjust stimulation settings has been developed,” Parkinson's disease is the second most common neurodegenerative disease after Alzheimer's. Approximately 400,000 people were affected with the disease in Germany in December 2022, and the numbers are increasing due to demographic aging. More and more people, including younger people, suffer from neurodegenerative diseases; in Germany, more than 2 million people have dementia or Parkinson's. According to the German Association for Alzheimer's Patients, in 2020, 9,450 people died from Alzheimer's, recording the highest figure. The increase in hospitalizations and deaths with Alzheimer's diagnosis is highly dependent on the aging population in Germany. People aged 65 and above increased by ~33% between and reached 18.3 million in 2020. Therefore, the aging population results in growing neurological disorders, which is expected to boost the market growth in the coming years.
Europe Deep Brain Simulation Market Segmentation
The Europe deep brain simulation market is segmented into product, application, end user, and country.
Based on product, the Europe deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the Europe deep brain simulation market.
Based on application, the Europe deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. In 2022, the Parkinson’s disease segment registered the largest share in the Europe deep brain simulation market.
Based on end user, the Europe deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the Europe deep brain simulation market.
Based on country, the Europe deep brain simulation market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. In 2022, Germany segment registered the largest share in the Europe deep brain simulation market.
Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corp, Medtronic Plc, and Newronika SpA are some of the leading companies operating in the Europe deep brain simulation market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 169.14 Million |
| Market Size by 2030 | US$ 319.88 Million |
| CAGR (2022 - 2030) | 8.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Deep Brain Simulation Market is valued at US$ 169.14 Million in 2022, it is projected to reach US$ 319.88 Million by 2030.
As per our report Europe Deep Brain Simulation Market, the market size is valued at US$ 169.14 Million in 2022, projecting it to reach US$ 319.88 Million by 2030. This translates to a CAGR of approximately 8.3% during the forecast period.
The Europe Deep Brain Simulation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Deep Brain Simulation Market report:
The Europe Deep Brain Simulation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Deep Brain Simulation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Deep Brain Simulation Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Deep Brain Simulation Market
